Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,365-2,376 of 10,592
Drug study icon
CompletedNCT05407064

A Dose-Finding Study of MM120 (LSD D-Tartrate) for Anxiety Symptoms

This study exists to explore whether the medication MM120 could improve care and understanding. Researchers are trying to understand whether the medication MM120 can give earlier or clearer feedback during care.

In United States
AnxietyDrugFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Anxiety
Behavioral study icon
Active Not RecruitingNCT04175041

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

This study is comparing Transcranial Direct Current Stimulation with Healthy Control for people with Attention Deficit Hyperactivity Disorder. Participants receive Transcranial Direct Current Stimulation or Healthy Control and complete study visits and assessments.

In United States
ADHDBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Drug study icon
CompletedNCT01996644

A Double Blind study of DCS for Food Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disorders, AnxietyDrugFrom 14 Years to 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Eating disorders, Anxiety
Drug study icon
CompletedNCT00376220

A Placebo Controlled study of Riluzole in Depression in bipolarity

This study is completed in the United States. It is testing Double-Blind Placebo Controlled Trial of Riluzole for depression in bipolarity.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00232414

Quetiapine for depression

This study is completed in the United States. It is testing quetiapine for depression.

In United States
Bipolarity, DepressionDrugFrom 12 Years to 18 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.